Dorris Pharmaceuticals Private Limited
About Dorris Pharmaceuticals Private Limited
Data last updated:
Dorris Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 August 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2009PTC193644. Its GSTIN is 07AADCD7829E1ZN (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Krishan Lal Lal and Priyanka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 92 Ravi Dass Nagar Narela, Delhi, India – 110040.
As per the financials filed for FY 2024, the company reported a revenue of ₹71.6 Lakh, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹63,902 (net margin 0.9%) and EBITDA of ₹1.76 Lakh (EBITDA margin 2.5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 8% over five years.
Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dorris Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address92 Ravi Dass Nagar Narela, Delhi, India – 110040
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dorris Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dorris Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dorris Pharmaceuticals Private Limited, buy the company report.
Financials of Dorris Pharmaceuticals Private Limited
FY 2025 filings availableDorris Pharmaceuticals Private Limited reported revenue of ₹71.6 Lakh (down 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 9% fall in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63,902 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dorris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dorris Pharmaceuticals Private Limited
Dorris Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishan Lal Lal Also directs: Arlis Creations Private Limited | Director | 20 Mar 2022 | 4 Years 7 Months | Current |
| Priyanka Also directs: Arlis Creations Private Limited, Arlis Health Care Private Limited | Director | 08 Feb 2013 | 13 Years 8 Months | Current |
Peer comparison
Dorris Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Styris Pharma Private Limited | ₹71.98 Lakh (FY 2021) | -32.0% | Telangana, India | |||
| Newmark Biosciences Private Limited | ₹71.96 Lakh (FY 2024) | -13.0% | Bareilly, Uttar Pradesh, India | |||
| Midlife Biosciences Private Limited | ₹71.68 Lakh (FY 2025) | 8.0% | Kanpur, Uttar Pradesh, India | |||
| Dorris Pharmaceuticals Private Limitedthis company | ₹71.6 Lakh (FY 2024) | ₹63,902 | 0.9% | -9.0% | Delhi, India | |
| Xylia Pharmaceuticals Private Limited | ₹71.26 Lakh (FY 2025) | -7.0% | Kozhikode, Kerala, India | |||
| San Smith Pharma Private Limited | ₹71.18 Lakh (FY 2025) | -28.0% | Kurukshetra, Haryana, India |
To see the full peer comparison of Dorris Pharmaceuticals Private Limited, buy the company report.
Auditor
Dorris Pharmaceuticals Private Limited is audited by R C P K & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R C P K & ASSOCIATES | FY 2021 | 025103N |
Shareholding
The shareholding of Dorris Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Dorris Pharmaceuticals Private Limited, buy the company report.
Legal cases
Dorris Pharmaceuticals Private Limited has 4 court cases on record: 2 filed by Dorris Pharmaceuticals, 2 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
| High courts | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Appeal | Filed against the company by Shri Op Sharma Proprietor of M/S Shree Vinayak Enterprises | Pending |
| High Court of Delhi | Court case (CRL.M.C.) | Filed against the company by Shri Op Sharma@Op Shashtri, Proprieor of M/S Shri Vinayak Enterprises | Disposed |
| District court, North, Delhi | Court case (CS (COMM.)) | Filed by the company against Op Sharma Prop M/S Shree Vinayak Enterprises | Disposed |
| District court, North, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Dorris Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dorris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dorris Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCD7829E1ZN | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dorris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dorris Pharmaceuticals Private Limited has 8 board changes on record since 2009: 5 appointments and 3 cessations. The latest: Nivenjeet Tiwari ceased to be Director on 10 Apr 2025.
Frequently asked questions
Dorris Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 August 2009 (17+ years old) and is registered under CIN U24100DL2009PTC193644.
Dorris Pharmaceuticals has 2 current directors:
- Krishan Lal Lal - Director
- Priyanka - Director
The latest financial statements of Dorris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dorris Pharmaceuticals is 07AADCD7829E1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Dorris Pharmaceuticals is U24100DL2009PTC193644. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dorris Pharmaceuticals has 4 court cases on record: 2 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.
Dorris Pharmaceuticals was incorporated on 28 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dorris Pharmaceuticals by revenue are Styris Pharma Private Limited, Newmark Biosciences Private Limited, Midlife Biosciences Private Limited, Xylia Pharmaceuticals Private Limited, San Smith Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Nivenjeet Tiwari ceased to be Director on 10 Apr 2025. Krishan Lal Lal was appointed as Director on 20 Mar 2022. Neelesh Tiwari ceased to be Director on 20 Jan 2016. Dorris Pharmaceuticals has 8 board changes on record in total.
The registered office of Dorris Pharmaceuticals is at 92 Ravi Dass Nagar Narela, Delhi, India – 110040.
Dorris Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
